Korean J Dermatol.  2000 Sep;38(9):1234-1238.

Keratoacanthoma and PUVA Keratoses in a Vitiligo Patient Following Oral Psoralen Photochemotherapy (PUVA)

Affiliations
  • 1Department of Dermatology Ewha Womans University, Seoul, Korea.

Abstract

Systemic PUVA therapy can produce various acute reactions and potential long-term damage including benign and malignant skin tumors. Obviously the risk is related to DNA damage, but PUVA-induced down-regulation of immune responses may play an additional role. Keratoacanthoma is etiologically related to sunlight and immunosuppression. PUVA keratoses are raised warty papules with a broad base and a diameter of several millimeters to 1 centimeter, and they are associated with an increased risk of nonmelanoma skin cancer. We report a case of solitary keratoacanthoma and multiple PUVA keratoses all developing in vitiliginous areas in a patient receiving long-term, high-dose PUVA therapy for generalized vitiligo. A 57-year-old Korean female, who had undergone intermittent systemic PUVA therapy for 11 years, noted multiple asymptomatic, yellowish, hyperkeratotic papules on the dorsa of hands and feet 1 year previously, and a bean-sized raised painful nodule filled with keratin plug on the dorsum of right hand 1 month previously. Skin biopsy confirmed the diagnoses of PUVA keratoses and keratoacanthoma, respectively. PCR-SSCP analysis revealed no mutation of p53 tumor suppressor gene in this case.

Keyword

Vitiligo; PUVA; PUVA keratosis; Keratoacanthoma

MeSH Terms

Biopsy
Diagnosis
DNA Damage
Down-Regulation
Female
Ficusin*
Foot
Genes, Tumor Suppressor
Hand
Humans
Immunosuppression
Keratoacanthoma*
Keratosis*
Middle Aged
Photochemotherapy*
PUVA Therapy
Skin
Skin Neoplasms
Sunlight
Vitiligo*
Ficusin
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr